D.A. Davidson & CO. Sells 63 Shares of Elevance Health, Inc. (NYSE:ELV)

D.A. Davidson & CO. lessened its stake in Elevance Health, Inc. (NYSE:ELVFree Report) by 1.1% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,588 shares of the company’s stock after selling 63 shares during the quarter. D.A. Davidson & CO.’s holdings in Elevance Health were worth $2,433,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. BDO Wealth Advisors LLC lifted its holdings in shares of Elevance Health by 266.7% in the second quarter. BDO Wealth Advisors LLC now owns 55 shares of the company’s stock valued at $25,000 after purchasing an additional 40 shares in the last quarter. Fortis Capital Advisors LLC bought a new position in shares of Elevance Health in the fourth quarter valued at approximately $29,000. TD Capital Management LLC bought a new position in shares of Elevance Health in the fourth quarter valued at approximately $30,000. OFI Invest Asset Management bought a new stake in Elevance Health during the third quarter worth $25,000. Finally, Householder Group Estate & Retirement Specialist LLC purchased a new position in Elevance Health in the third quarter worth $30,000. Institutional investors own 87.80% of the company’s stock.

Analysts Set New Price Targets

Several research firms have weighed in on ELV. Cantor Fitzgerald reissued an “overweight” rating and issued a $547.00 price objective on shares of Elevance Health in a research report on Friday, February 2nd. Morgan Stanley boosted their price objective on Elevance Health from $585.00 to $587.00 and gave the stock an “overweight” rating in a research report on Thursday, October 19th. Royal Bank of Canada boosted their price objective on Elevance Health from $572.00 to $574.00 and gave the stock an “outperform” rating in a research report on Thursday, January 25th. JPMorgan Chase & Co. cut their price objective on Elevance Health from $569.00 to $552.00 and set an “overweight” rating on the stock in a research report on Friday, November 17th. Finally, StockNews.com cut Elevance Health from a “strong-buy” rating to a “buy” rating in a research report on Thursday, January 25th. Two investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Elevance Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $564.60.

Get Our Latest Stock Report on ELV

Elevance Health Stock Up 0.9 %

Shares of NYSE ELV opened at $502.05 on Friday. The business’s fifty day moving average price is $478.49 and its 200-day moving average price is $464.51. The stock has a market capitalization of $117.98 billion, a PE ratio of 19.95, a P/E/G ratio of 1.10 and a beta of 0.78. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.44 and a quick ratio of 1.41. Elevance Health, Inc. has a one year low of $412.00 and a one year high of $504.08.

Elevance Health (NYSE:ELVGet Free Report) last issued its quarterly earnings data on Wednesday, January 24th. The company reported $5.62 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.60 by $0.02. The business had revenue of $42.45 billion for the quarter, compared to analysts’ expectations of $42.19 billion. Elevance Health had a return on equity of 20.47% and a net margin of 3.49%. The firm’s quarterly revenue was up 7.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $5.23 EPS. On average, equities research analysts anticipate that Elevance Health, Inc. will post 37.14 EPS for the current year.

Elevance Health Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 22nd. Investors of record on Friday, March 8th will be issued a dividend of $1.63 per share. This is a boost from Elevance Health’s previous quarterly dividend of $1.48. The ex-dividend date is Thursday, March 7th. This represents a $6.52 dividend on an annualized basis and a yield of 1.30%. Elevance Health’s dividend payout ratio is 23.52%.

Elevance Health Company Profile

(Free Report)

Elevance Health, Inc operates as a health benefits company. The company operates through four segments: Commercial & Specialty Business, Government Business, CarelonRx, and Other. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives.

Further Reading

Institutional Ownership by Quarter for Elevance Health (NYSE:ELV)

Receive News & Ratings for Elevance Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevance Health and related companies with MarketBeat.com's FREE daily email newsletter.